Stocktoria
Lantern Pharma Inc. LTRN
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2020-06-11
Lantern Pharma Inc. statistics & valuation
Market cap$49.2M
P / B7.5×
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Return on assets | -155.1% | -81.3% | -36.6% | -24.2% | -16.7% |
| Return on equity | -262.0% | -98.1% | -39.0% | -25.4% | -17.3% |
| Current ratio | 2.40 | 5.83 | 16.18 | 20.99 | 31.26 |
Source: SEC EDGAR filings · CIK 0001763950 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.